Author

Diego M. Cantoni

Medway School of PharmacyORCID 0000-0001-8527-7719Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Nigel James TempertoniD· 2 shared Arvind H. PateliD· 1 shared Brian Willet· 1 shared Bridget Larman· 1 shared Charlotte L. GeorgeiD· 1 shared Chloe Qingzhou HuangiD· 1 shared Christopher DavisiD· 1 shared Connor BamfordiD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Nigel James TempertonORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

MicrobiologybioRxivPreprintJul 6, 2026

SARS-CoV-2 Spike H655Y drives protease preference but does not dictate cellular tropism

Diego M. Cantoni, Wilhelm Furnon, Sarah Little…·Joe Grove

This study shows that the SARS-CoV-2 Spike H655Y mutation changes protease preference but does not determine cellular tropism, with RBD interactions being more critical for upper airway adaptation.

DOI 10.64898/2026.07.05.736580

humanbulk RNA-seq

𝕏 PostBluesky

MicrobiologybioRxivPreprintOct 17, 2025

Serological evidence of SARS-CoV-2 infection in red and fallow deer in Great Britain.

Joanna Vieira O'Neill, Joash Tan, Ed Long…·George Carnell

The paper reports high seroprevalence of SARS-CoV-2 in British deer, indicating potential reservoir capability and zoonotic risks from human-deer interactions.

DOI 10.1101/2025.10.17.682775

proteomicsexperimental assay

𝕏 PostBluesky

MicrobiologybioRxivPreprintAug 14, 2025

Cross-Neutralizing Monoclonal Antibodies with Broad Activity Against Human and Bat-Derived SARS-Related Coronaviruses

Martin Mayora Neto, Kelly da Costa, Diego M. Cantoni…·Nigel James Temperton

The paper identifies monoclonal antibodies that neutralize multiple SARS-CoV-1, SARS-CoV-2 variants, and bat coronaviruses, with one antibody showing broad cross-reactivity.

1 citation

humanproteomics

𝕏 PostBluesky